4
Changes in Ownership
Teladoc Health, Inc. Filed Acc 0001415889-22-002589
CHIEF MARKETING OFFICER sold 2,858 shares at $70.24 ($200,743)
- CHIEF MARKETING OFFICER acquired 7,670 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Verstraete Stephany CHIEF MARKETING OFFICER | 2022-03-02 | Option exercise | +1,808 | 24,086 | D | ||
| Verstraete Stephany CHIEF MARKETING OFFICER | 2022-03-02 | Option exercise | +3,074 | 27,160 | D | ||
| Verstraete Stephany CHIEF MARKETING OFFICER | 2022-03-02 | Option exercise | +773 | 27,933 | D | ||
| Verstraete Stephany CHIEF MARKETING OFFICER | 2022-03-02 | Option exercise | +1,147 | 29,080 | D | ||
| Verstraete Stephany CHIEF MARKETING OFFICER | 2022-03-02 | Option exercise | +868 | 29,948 | D | ||
| Verstraete Stephany CHIEF MARKETING OFFICER | 2022-03-03 | Sale | −2,858 | $70.24 | $200,743 | 27,090 | D |
| Derivatives | |||||||
| Verstraete Stephany CHIEF MARKETING OFFICER | 2022-03-02 | Option exercise · Restricted Stock Units | −1,808 | 1,807 | D | ||
| Verstraete Stephany CHIEF MARKETING OFFICER | 2022-03-02 | Option exercise · Performance Stock Units | −3,074 | 3,072 | D | ||
| Verstraete Stephany CHIEF MARKETING OFFICER | 2022-03-02 | Grant or award · Performance Stock Units | +1,545 | 1,545 | D | ||
| Verstraete Stephany CHIEF MARKETING OFFICER | 2022-03-02 | Option exercise · Performance Stock Units | −773 | 772 | D | ||
| Verstraete Stephany CHIEF MARKETING OFFICER | 2022-03-02 | Option exercise · Restricted Stock Units | −1,147 | 2,295 | D | ||
| Verstraete Stephany CHIEF MARKETING OFFICER | 2022-03-02 | Grant or award · Performance Stock Units | +2,602 | 2,602 | D | ||
| Verstraete Stephany CHIEF MARKETING OFFICER | 2022-03-02 | Option exercise · Performance Stock Units | −868 | 1,734 | D | ||
| Open-market sales · 2,858 sh · avg $70.24 · $200,743 | |||||||
Loading xslF345X03/form4-03042022_030338.xml…